These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 38665551)
1. Identification of exosome-related gene signature as a promising diagnostic and therapeutic tool for breast cancer. Chen Q; Zhou Q Heliyon; 2024 Apr; 10(8):e29551. PubMed ID: 38665551 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer. Qiu P; Guo Q; Yao Q; Chen J; Lin J Front Immunol; 2021; 12():736030. PubMed ID: 34659224 [TBL] [Abstract][Full Text] [Related]
3. An exosome-related long non-coding RNAs risk model could predict survival outcomes in patients with breast cancer. Qiu P; Guo Q; Lin J; Pan K; Chen J; Ding M Sci Rep; 2022 Dec; 12(1):22322. PubMed ID: 36566321 [TBL] [Abstract][Full Text] [Related]
4. Identification of an exosome-related signature associated with prognosis and immune infiltration in breast cancer. Guo Q; Pan K; Qiu P; Liu Z; Chen J; Lin J Sci Rep; 2023 Oct; 13(1):18198. PubMed ID: 37875600 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer. Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M Front Immunol; 2022; 13():891175. PubMed ID: 35990668 [TBL] [Abstract][Full Text] [Related]
6. Homologous repair deficiency-associated genes in invasive breast cancer revealed by WGCNA co-expression network analysis and genetic perturbation similarity analysis. Chen H; Liu Y; Yin Z; Chen H; Wang Y; Qian Y Cell Cycle; 2023 May; 22(9):1077-1100. PubMed ID: 36757135 [TBL] [Abstract][Full Text] [Related]
7. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer. Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W J Oncol; 2022; 2022():5468858. PubMed ID: 36467500 [TBL] [Abstract][Full Text] [Related]
8. Construction and validation of a prognostic marker and risk model for HCC ultrasound therapy combined with WGCNA identification. Bi Y; Jing Y; Guo L Front Genet; 2022; 13():1017551. PubMed ID: 36263426 [No Abstract] [Full Text] [Related]
9. Comprehensive Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B Front Immunol; 2022; 13():931906. PubMed ID: 35958598 [TBL] [Abstract][Full Text] [Related]
10. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma. Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X Front Oncol; 2023; 13():1182434. PubMed ID: 37346073 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive research into prognostic and immune signatures of transcription factor family in breast cancer. Wu Q; Zheng S; Lin N; Xie X BMC Med Genomics; 2023 Apr; 16(1):87. PubMed ID: 37098532 [TBL] [Abstract][Full Text] [Related]
12. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer. Yu Z; Zhu Y; Ji J Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486 [TBL] [Abstract][Full Text] [Related]
13. An exosome-derived lncRNA signature identified by machine learning associated with prognosis and biomarkers for immunotherapy in ovarian cancer. Cui Y; Zhang W; Lu W; Feng Y; Wu X; Zhuo Z; Zhang D; Zhang Y Front Immunol; 2024; 15():1228235. PubMed ID: 38404588 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive study based on exosome-related immunosuppression genes and tumor microenvironment in hepatocellular carcinoma. Yang Z; Li X; Pan C; Li Y; Lin L; Jin Y; Zheng J; Yu Z BMC Cancer; 2022 Dec; 22(1):1344. PubMed ID: 36550445 [TBL] [Abstract][Full Text] [Related]
15. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis. Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405 [TBL] [Abstract][Full Text] [Related]
16. 5 signature genes revealed by single-cell profiling identified unique immune subtypes affecting the prognosis of ovarian cancer. Xiang SY; Li QK; Yang Z; Yi Q Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):2051-2062. PubMed ID: 38497886 [TBL] [Abstract][Full Text] [Related]
17. Integrating single-cell and bulk transcriptomic analyses to develop a cancer-associated fibroblast-derived biomarker for predicting prognosis and therapeutic response in breast cancer. Li C; Yang L; Zhang Y; Hou Q; Wang S; Lu S; Tao Y; Hu W; Zhao L Front Immunol; 2023; 14():1307588. PubMed ID: 38235137 [TBL] [Abstract][Full Text] [Related]
18. Establishment of a lysosome-related prognostic signature in breast cancer to predict immune infiltration and therapy response. Su H; Chen Y; Lin F; Li W; Gu X; Zeng W; Liu D; Li M; Zhong S; Chen Q; Chen Q Front Oncol; 2023; 13():1325452. PubMed ID: 38162504 [TBL] [Abstract][Full Text] [Related]
19. A prognostic exosome-related long non-coding RNAs risk model related to the immune microenvironment and therapeutic responses for patients with liver hepatocellular carcinoma. Yue Y; Tao J; An D; Shi L Heliyon; 2024 Jan; 10(2):e24462. PubMed ID: 38293480 [TBL] [Abstract][Full Text] [Related]
20. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer. Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G Front Genet; 2022; 13():919389. PubMed ID: 35783281 [No Abstract] [Full Text] [Related] [Next] [New Search]